CClinicalTrials.gg
CompletedNCT04362696Updated Jul 23, 2026

Improving Working Memory in Older Adults

An interventional study of High definition transcranial electrical current stimulation in Memory Disorders in Old Age, sponsored by Boston University Charles River Campus. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-23.

Sponsored by Boston University Charles River Campus · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Sep 2019, registered Apr 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
964
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The research program will evaluate the theoretical claim that age-related memory and cognitive decline in humans result from the inefficient orchestration of rhythmic activity within large-scale cortical networks. The results will contribute to the basic science groundwork for developing future non-pharmacological interventions aimed at boosting memory and cognition in aging and clinical populations.

Read the detailed description

The investigators hypothesize that aged-related memory and cognitive impairments emerge from large-scale functional dysconnectivity and by stimulating the brain noninvasively with extremely weak levels of electrical current, it may be possible to re-synchronize connectivity and stabilize or improve memory and cognitive function, measured behaviorally. The experiments of this project are proposed as between-subjects, sham-controlled, and double-blind in design, and use noninvasive electroencephalographic (EEG) measurements of rhythmic brain activity. The experimental intervention involves the application of low-intensity, high-definition, transcranial electrical current stimulation while subjects perform a variety of computer-based tasks that probe memory and cognitive function.

02

Conditions studied

  • Memory Disorders in Old Age

Keywords

  • aged-related memory
  • cognitive decline
  • transcranial electrical current stimulation
03

In context

Cognitive Dysfunction

3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.

This study's enrollment of 964 is above the median of 65 across 2,808 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Boston University Charles River Campus is the lead sponsor of 154 studies on the registry; 30 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 8 (57%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • For Experiment 1, 18-30 years
  • For Experiment 2, 60-80 years
  • Normal or corrected-to-normal vision
  • Has color vision.

Exclusion criteria

Exclusion criteria

  • Metal implants in the head
  • Implanted electronic devices
  • A history of neurological problems or head injury
  • Skin sensitivity
  • Claustrophobia
  • Dementia [Mini Mental State Examination (MMSE) score of 23 or lower; Montreal Cognitive Assessment score of \<26)
  • Depression [Beck Depression Inventory II score of 14 or higher; Geriatric Depression Scale score of 10 or higher]
  • Taking any psychoactive medication
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
964 participants (actual)

Study arms

  • Experimental
    active stimulation

    Device: High definition transcranial electrical current stimulation

  • Sham comparator
    sham stimulation

    Device: High definition transcranial electrical current stimulation

Interventions

  • DeviceHigh definition transcranial electrical current stimulation

    Low-intensity and safe, noninvasive application of electrical current to the human scalp with the goal of gradually modulating levels of neuronal excitability.

06

What researchers measure

Primary outcomes

  1. Memory performance success (sham stimulation condition)

    The accuracy of task performance (in percentage correct units) in the delayed-match-to-sample working memory paradigm

    Time frame: During sham intervention

  2. Memory performance success (active stimulation condition)

    The accuracy of task performance (in percentage correct unit) in the delayed-match-to-sample working memory paradigm

    Time frame: During active intervention

  3. Memory performance speed (sham stimulation condition)

    The reaction time of task performance (in millisecond units) in the delayed-match-to-sample working memory paradigm

    Time frame: During sham intervention

  4. Memory performance speed (active stimulation condition)

    The reaction time of task performance (in millisecond units) in the delayed-match-to-sample working memory paradigm

    Time frame: During active intervention

07

Study locations

1 site
  • 111 Cummington Mall Room 264
    Boston, Massachusetts 02215, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04362696
Lead sponsor
Boston University Charles River Campus
Responsible party
Robert Reinhart (Assistant Professor, Boston University Charles River Campus) — Principal investigator
First posted
Apr 27, 2020
Start date
Sep 1, 2019
Primary completion
Apr 30, 2026
Completion
Apr 30, 2026
Last update
Jul 23, 2026

Study contacts

Robert MG Reinhart, PhD
principal investigator · Boston University Charles River Campus

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion